2020
DOI: 10.1615/jlongtermeffmedimplants.2020035938
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Osseointegration and Crestal Bone Loss Associated with Implants Placed in Diabetic and Other Medically Compromised Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Patients suffering from diabetes mellitus and who do not control their blood sugar levels are much more likely to develop peri-implantitis after the completion of a dental implant compared to healthy patients or patients who maintain their glycemic level under control. Soh [31] confirms the abovementioned data, emphasizing that there is a significant difference between patients suffering from this condition and healthy ones [32]. Due to this, doctors must be more careful when performing dental implants in patients suffering from diabetes.…”
Section: Predisposition To Develop Peri-implantitissupporting
confidence: 74%
“…Patients suffering from diabetes mellitus and who do not control their blood sugar levels are much more likely to develop peri-implantitis after the completion of a dental implant compared to healthy patients or patients who maintain their glycemic level under control. Soh [31] confirms the abovementioned data, emphasizing that there is a significant difference between patients suffering from this condition and healthy ones [32]. Due to this, doctors must be more careful when performing dental implants in patients suffering from diabetes.…”
Section: Predisposition To Develop Peri-implantitissupporting
confidence: 74%
“… 24 n.d. n.d. 2 HbA1c < 6% k.A. Three groups: HbA1c ≤ 6% (controls included); HbA1c = 6.1–8%; HbA1c = 8.1–10% n.d. de Araujo Nobre et al (2016) Retrospective 70 59(41–80) 1999–2007 60 352 89.8; group with type 1 diabetes mellitus: 80; group with type 1 diabetes mellitus: 90.5 1 and 2 No controlgroup “Treated”; no further information n.d. n.d. Al Amri et al (2017) [ 26 ] Retrospective 108 Immediately loaded group: 50.6 ± 2.2; conventional loading group 51.8 ± 1.7 n.d. 24 108 100 2 No controlgroup n.d. No initial HbA1c; At 12- and 24-month follow-up, the mean HbA1c levels in group 1 (immediately loading) and 2 (conventional loading) were 5.4%(4.8–5.5%) and 5.1%(4.7–5.4%) and 5.1%(4.7–5.2%) and 4.9%(4.5–5.2%) Immediately loaded group: 9.2 ± 2.4 years; conventional loaded 8.5 ± 0.4 years Al Amri et al (2017) [ 27 ] Prospective 45 Diabetic group: 42.4(40–46); nondiabetic group: 41.8(39–44) n.d. 24 45 n.d. 2 HbA1c < 4.5% (visually, boxplot) Antihyperglycemic drugs, dietary control “Well controlled”: no exact data given, but visually (boxplots) the baseline HbA1c is significantly higher in the diabetic group (visually < 7%) than in nondiabetic control group (visually < 4.5%) 14.5 ± 0.7 months Soh et al (2020) [ 28 ] …”
Section: Resultsmentioning
confidence: 99%
“…12 clinical studies (1× cross-sectional study, 5× prospective, 6× retrospective) showed no increased risk of developing peri-implantitis with manifest diabetes mellitus [ 17 , 23 , 24 , 27 , 34 , 38 41 , 44 , 46 , 77 ]. On the other hand, six studies indicated an increased risk of peri-implant inflammation, with the highest determined relative risk being given as 8.65 [ 15 , 28 , 31 , 48 ]. Two of these publications showed this especially in poorly controlled diabetes mellitus with an HbA1c > 8% with increased probing depths, bleeding on probing and peri-implant bone resorption [ 19 , 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…41 When comparing non-diabetic and diabetic individuals, a recent systematic review found no significant difference in implant survival rates. 15 In the longterm, an elevated HbA1c level has been associated with an increased risk for microvascular complications 42 and periimplant inflammation, 15 leading to increased marginal bone loss 41,43,44 and peri-implantitis. Although PC T2DM has been associated with a higher risk of early dental implant complications, only one implant in the present study was diagnosed with peri-implant mucositis and there were no significant inter-group differences or adverse effects.…”
Section: Discussionmentioning
confidence: 99%